Gujarat Inject (Kerala) Ltd.
Bombay Stock ExchangeTotal Valuation
Gujarat Inject (Kerala) Ltd. carries a market capitalization of 1.92B, placing it among publicly traded companies globally. Its enterprise value stands at 1.08B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 1.92B |
| Enterprise Value | 1.08B |
Share Statistics
Gujarat Inject (Kerala) Ltd. currently has 14.65M shares outstanding.
| Shares Outstanding | 14.65M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Gujarat Inject (Kerala) Ltd. trades at a trailing price-to-earnings ratio of 59.78. The price-to-sales ratio is 2.99, and the price-to-book ratio stands at 7.41.
| PE Ratio | 59.78 |
| PS Ratio | 2.99 |
| PB Ratio | 7.41 |
| P/TBV Ratio | 9.17 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
Enterprise Valuation
On an enterprise value basis, Gujarat Inject (Kerala) Ltd. trades at an EV/EBITDA multiple of 46.78 and an EV/FCF ratio of 743,812.36. The EV/Sales ratio of 2.97 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 46.78 provides insight into valuation relative to core operating earnings.
| EV / Sales | 2.97 |
| EV / EBITDA | 46.78 |
| EV / EBIT | 46.78 |
| EV / FCF | 743,812.36 |
Financial Position
Gujarat Inject (Kerala) Ltd. maintains a current ratio of 0.47, meaning it holds 0.5x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 0.47 |
| Quick Ratio | 0.03 |
| Debt / Equity | N/A |
| Debt / EBITDA | N/A |
| Interest Coverage | 11,519.50 |
Financial Efficiency
Gujarat Inject (Kerala) Ltd. posts a return on equity of 12.40 and a return on invested capital of 14.86.
| Return on Equity (ROE) | 12.40 |
| Return on Assets (ROA) | 7.46 |
| Return on Invested Capital (ROIC) | 14.86 |
| Return on Capital Employed (ROCE) | 12.40 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Taxes
Over the trailing twelve months, Gujarat Inject (Kerala) Ltd. has paid 6.90M in income taxes, reflecting an effective tax rate of 27.55.
| Income Tax | 6.90M |
| Effective Tax Rate | 27.55 |
Stock Price Statistics
Gujarat Inject (Kerala) Ltd.'s stock has gained approximately 440.25599% over the past 52 weeks. The 50-day moving average sits at 112.85, while the 200-day moving average is 63.25.
| Beta (5Y) | N/A |
| 52-Week Price Change | 440.25599% |
| 50-Day Moving Average | 112.85 |
| 200-Day Moving Average | 63.25 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Gujarat Inject (Kerala) Ltd. generated 363.20M in revenue and converted that into 18.14M in net income, yielding earnings per share of 1.31. EBITDA reached 23.04M, while operating income came in at 23.04M.
| Revenue | 363.20M |
| Gross Profit | 26.93M |
| Operating Income | 23.04M |
| Pretax Income | 25.04M |
| Net Income | 18.14M |
| EBITDA | 23.04M |
| EBIT | 23.04M |
| Earnings Per Share (EPS) | 1.31 |
Balance Sheet
Total book value stands at 146.35M, with working capital of -132.72M providing operational flexibility.
| Cash & Cash Equivalents | 6.78M |
| Total Debt | N/A |
| Net Debt | -6.78M |
| Equity (Book Value) | 146.35M |
| Book Value Per Share | 10.55 |
| Working Capital | -132.72M |
Margins
Gujarat Inject (Kerala) Ltd. operates with a gross margin of 7.41, reflecting its pricing power and cost economics. The operating margin of 6.34 and net profit margin of 4.99 provide insight into operational efficiency.
| Gross Margin | 7.41 |
| Operating Margin | 6.34 |
| Pretax Margin | 6.89 |
| Profit Margin | 4.99 |
| EBITDA Margin | 6.34 |
Stock Splits
Gujarat Inject (Kerala) Ltd.'s most recent stock split took place on July 8, 2026 with a 1:10 split ratio.
| Last Split Date | 7/8/2026 |
| Split Ratio | 1:10 |
Scores
Gujarat Inject (Kerala) Ltd. posts an Altman Z-Score of 3.38, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 3.38 |